Jerrold Rosenbaum is a Psychiatry physician affiliated with Massachusetts General Hospital. OpenAlex indexes 313 publications with 28,650 citations (h-index 84). By OpenAlex citation count, this profile ranks in the top 5% of Psychiatry profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
55 Fruit Street
Bulfinch 351
Boston, MA 021143117
Telephone
617-726-3482Registry record last updated 7 Nov 2012.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Benzodiazepine36.4%Clonazepam39%Alprazolam35%Lorazepam27%Part D<11 patientsSSRI16.8%Trazodone Hcl54%Escitalopram Oxalate46%Part D<11 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 1992–2008 per NIH RePORTER. The latest:
- Children at Risk for Anxiety Disorders: A Follow up Study
Massachusetts General Hospital
FY2008$635,105R01MH047077 - Family Imaging Study of Children at Risk for Anxiety
Massachusetts General Hospital
FY2008$462,716R01MH074848 - Children at Risk for Anxiety Disorders: A Follow up Study
Massachusetts General Hospital
FY2007$654,472R01MH047077
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pharmacological approaches to the challenge of treatment-resistant depression
Dialogues in Clinical Neuroscience
2015 - PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder2010
- Cognitive behavioral therapy for 4- to 7-year-old children with anxiety disorders: A randomized clinical trial.
Journal of Consulting and Clinical Psychology
2010 - Influence of RGS2 on Anxiety-Related Temperament, Personality, and Brain Function
Archives of General Psychiatry
2008
Similar KOLs
Other experts from the same institution or the same specialty.
James Januzzi, MD
Massachusetts General Hospital
Maurizio Fava, MD
Massachusetts General Hospital
Steven Greenberg, MD
Massachusetts General Hospital
David Scadden, MD
Massachusetts General Hospital
Charles Nemeroff, MD
Dell Medical School
Maurizio Fava, MD
Massachusetts General Hospital
John Krystal, MD
Yale University
Jeffrey Lieberman, MD
Columbia University College of Physicians and Surgeons
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”